About This 510(k) Submission
K162788 is an FDA 510(k) clearance for the ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA, a System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi) (Class II — Special Controls, product code MSV), submitted by Immco Diagnostics, Inc. (Clarence, US). The FDA issued a Cleared decision on June 19, 2017, 259 days after receiving the submission on October 3, 2016. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5660.